Document is current
Any future updates will be listed below
-
Authors
Poluga, Claudia
Dheda, Shahtaj S.
Boachie, Nadia
McCluskey, Tina https://orcid.org/0000-0002-6795-4808
Narciso, Lucas
Zilberman, Maia
Côté, Cassie https://orcid.org/0009-0003-4350-6618
Huestis, Marilyn A. https://orcid.org/0000-0003-2137-4645
Tyndale, Rachel F.
Kloiber, Stefan https://orcid.org/0000-0002-6838-4114
Kolla, Nathan J.
Rusjan, Pablo M. https://orcid.org/0000-0003-0075-2918
Le Foll, Bernard https://orcid.org/0000-0002-6406-4973
Warsh, Jerry J.
George, Tony P. https://orcid.org/0000-0003-1645-9767
Boileau, Isabelle https://orcid.org/0000-0002-9901-1484
-
Funding
Funding for this research was provided by:
Canada Research Chairs (202004CRC)
- License Information
-
More Information
Article History
Received: 29 January 2026
Revised: 8 April 2026
Accepted: 27 April 2026
First Online: 9 May 2026
Competing interests
: CP, SSD, NB, TM, LN, MZ, CC, MAH, RFT, SK, NJK, PMR, JJW, IB have no disclosures. BLF has obtained funding from Indivior for a clinical trial sponsored by Indivior. BLF has in-kind donations of placebo edibles from Indiva. BLF has obtained industry funding from Canopy Growth Corporation (through research grants handled by the Center for Addiction and Mental Health and the University of Toronto). BLF has participated in a session of a National Advisory Board Meeting (Emerging Trends BUP-XR) for Indivior Canada and was part of Steering Board for a clinical trial for Indivior. BLF has been consultant for Shinogi, ThirdBridge and Changemark. He is part of a scientific advisory board for NFL Biosciences. BLF serves as an Editorial Board member for Neuropsychopharmacology (NPP), the official journal of The American College of Neuropsychopharmacology (ACNP). BLF got travel support to attend an event by Bioprojet. BLF is supported by CAMH, Waypoint Center for Mental Health Care, a clinician-scientist award from the department of Family and Community Medicine of the University of Toronto and a Chair in Addiction Psychiatry from the department of Psychiatry of University of Toronto. TPG serves as the Co-Principal Editor for Neuropsychopharmacology (NPP), the official journal of The American College of Neuropsychopharmacology (ACNP).
